8-K/A

AMENDMENT TO 8-K FILING

Company: Emmaus Life Sciences, Inc.
Filed: April 30, 2020
Period of Report: March 27, 2020
Accession Number: 0001213900-20-010618

View Document ↗ View on SEC.gov ↗